IP Library Granted Patent US 7,056,503
Granted Patent B2
US 7,056,503 · App. 09/962,059 · Granted Jun 6, 2006

Enclosures housing cell-coated supports for treating tumors

Assignee: Regents of the University of Michigan
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,056,503
App. No.
09/962,059
Granted
Jun 6, 2006
Kind
B2
Abstract

The present invention relates to devices, systems and methods for treating tumors. In particular, the present invention relates to enclosures housing cell-coated supports for promoting regression of tumors, such as cancerous tumors, papillomas, and warts. In preferred embodiments, the present invention provides methods of promoting tumor regression employing enclosures secreting therapeutic proteins.

Claims (30)

1. A method for promoting tumor regression, comprising;

a) providing;

i) viable cells on solid support material, wherein said viable cells secrete recombinant human interleukin-1 beta protein,

ii) an enclosure housing said solid support material, wherein said enclosure comprises mesh material, and

iii) a subject with a tumor, wherein said tumor comprises metastatic melanoma cells, and,

b) positioning said enclosure on said tumor of said subject such that regression of said tumor is promoted and such that metastasis of said melanoma cells to lung tissue of said subject is inhibited.

2. The method of claim 1 , wherein said viable cells comprise an expression vector, wherein said expression vector comprises a nucleic acid sequence encoding said interleukin-1 beta protein.

3. The method of claim 1 , wherein said solid support comprises beads.

4. The method of claim 1 , wherein said mesh material comprises pores.

5. The method of claim 1 , wherein said mesh material comprises pores ranging in size from about 1 micron to about 500 microns.

6. The method of claim 1 , wherein said enclosure further comprises a removal component.

7. The method of claim 1 , further comprising step c) removing said enclosure from said tumor after regression of said tumor is promoted.

8. The method of claim 1 , wherein said tumor is a cancerous tumor.

9. The method of claim 8 , wherein said cancerous tumor is a skin cancer tumor.

10. The method of claim 1 , wherein said viable cells are human foreskin cells.

11. A method for promoting tumor regression, comprising;

a) providing;

i) viable cells on solid support material, wherein said viable cells secrete recombinant human interleukin1 beta, and wherein said viable cells do not secrete recombinant human interleukin1 alpha,

ii) an enclosure housing said solid support material, wherein said enclosure comprises mesh material, and

iii) a subject with a tumor, wherein said tumor comprises metastatic melanoma cells, and

b) positioning said enclosure on said tumor of said subject such that regression of said tumor is promoted and such that metastasis of said melanoma cells to lung tissue of said subject is inhibited.

12. The method of claim 11 , wherein said viable cells comprise an expression vector, wherein said expression vector comprises a nucleic acid sequence encoding said interleukin1 beta protein.

13. The method of claim 11 , wherein said solid support comprises beads.

14. The method of claim 11 , wherein said mesh material comprises pores.

15. The method of claim 11 , wherein said mesh material comprises pores ranging in size from about 1 micron to about 500 microns.

16. The method of claim 11 , wherein said enclosure further comprises a removal component.

17. The method of claim 11 , further comprising step c) removing said enclosure from said tumor after regression of said tumor is promoted.

18. The method of claim 11 , wherein said tumor is a cancerous tumor.

19. The method of claim 18 , wherein said cancerous tumor is a skin cancer tumor.

20. The method of claim 11 , wherein said viable cells are human foreskin cells.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 11, 2018
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047468/0331 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Oct 8, 2008
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021647/0060 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2002
From: REES, RILEY; KIM, JIYOUN; REMICK, DANIEL; ADAMSON, BELINDA
To: REGENTS OF THE UNIVERSITY OF MICHIGAN, THE
Reel/Frame 012727/0270 →
Continuity (3)
Continuation In Part 0964099000 · Aug 18, 2000
Provisional Application 6014974400 · Aug 19, 1999
Related Publication 20030007955A1 · Jan 9, 2003